'מערכת אימד'- Abstract
Objective: To summarize efficacy data from two phase 2 and two phase 3 short-term, multicenter, randomized, double-blind, placebo-controlled studies of brexpiprazole adjunctive to antidepressant treatments (ADTs) in patients with major depressive disorder (MDD) with inadequate response to ADTs.
Thase E. Michael, Zhang Peter, Skuban Aleksandar, Hobart Mary, Weiss Catherine, Weiller Emmanuelle and Nelson C. James, Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview, Current Psychiatry Reviews 2016; 12(3) . https://dx.doi.org/10.2174/1573400512999160901094451